USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth

Participants:

Heiskanen Pasi Chief Operating OfficerNoona by Varian Medical Systems
Heiskanen Pasi
Chief Operating OfficerNoona by Varian Medical Systems
Kasparas Aleknavicius Medical AdvisorKilo.Health
Kasparas Aleknavicius
Medical AdvisorKilo.Health
BB
Bill Bunker CEONavigating Cancer
BB
Bill Bunker
CEONavigating Cancer
Brian Flatley VP Consulting Services & US Pharma SolutionsS3 Connected Health
Brian Flatley
VP Consulting Services & US Pharma SolutionsS3 Connected Health
Chris Cera CEOArcweb Technologies
Chris Cera
CEOArcweb Technologies
Conchuir MacGloinn Strategic Partnerships ManagerRoche Hoffman
Conchuir MacGloinn
Strategic Partnerships ManagerRoche Hoffman
FE
Fayez El-Shakfeh Head of OncologyBayer
FE
Fayez El-Shakfeh
Head of OncologyBayer
Jai Pandey Global Head, Device Regulatory for IVD/CDxSanofi
Jai Pandey
Global Head, Device Regulatory for IVD/CDxSanofi
John Gordon Commercial Lead, International MarketsPfizer
John Gordon
Commercial Lead, International MarketsPfizer
Lynda Chin Co-Founder, President and CEOApricity
Lynda Chin
Co-Founder, President and CEOApricity
Mark Grossman VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works
Mark Grossman
VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works
Till Bauer Global Oncology LCM Strategy DirectorMSD
Till Bauer
Global Oncology LCM Strategy DirectorMSD

About this Meeting

Cancer is a source of significant and growing mortality worldwide. In 2020, it was the therapeutic area with more capital invested in digital health, 12% of venture funding in digital health was focused on oncology companies.

Recent results in JAMA (https://cutt.ly/RjIOIS9 & https://cutt.ly/njIOPM5) show that digital symptom monitoring during chemotherapy can help patients improve quality of life, live longer and reduce hospitalisation and ER visits. There is a gap in oncology to be addressed around broader care for the patient’s overall wellbeing; what impact might Remote Patient Monitoring (RPM) solutions have on the quality of life? Can they help address fatigue, nutrition, caregiver support and education? Are the digital solutions focused on quality of life the ones with the greatest opportunity in oncology? What are the attitudes of centers of excellence and community Oncologists on the use and value of RPM tools in their cancer patients?  Join this informal conversation with other thought leaders to discuss the current state and the exciting future of digital health in oncology.